Compare AHCO & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AHCO | MLAB |
|---|---|---|
| Founded | 2012 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 756.4M | 719.9M |
| IPO Year | 2017 | 1995 |
| Metric | AHCO | MLAB |
|---|---|---|
| Price | $5.77 | $134.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $13.50 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 2.5M | 105.7K |
| Earning Date | 05-05-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | N/A | ★ 0.49 |
| Revenue | ★ $3,244,857,000.00 | N/A |
| Revenue This Year | $9.00 | $6.07 |
| Revenue Next Year | $6.93 | $5.41 |
| P/E Ratio | ★ N/A | $269.12 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.21 | $63.48 |
| 52 Week High | $13.43 | $132.70 |
| Indicator | AHCO | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | 69.25 |
| Support Level | $5.27 | $94.20 |
| Resistance Level | $5.95 | N/A |
| Average True Range (ATR) | 0.30 | 4.28 |
| MACD | 0.09 | -0.06 |
| Stochastic Oscillator | 17.19 | 100.00 |
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.